Tarsons Products (TARSONS) | Stock Overview & Key Data
Tarsons Products Performance Comparison
Stock Range
Today's Range
Low: ₹326.25
High: ₹332.60
on August 22, 2025
52 Week Range
Low: ₹280.00
High: ₹491.80
on February 18, 2025
on September 18, 2024
All-Time High: ₹924.90 on November 29, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR17.6B
EPS
5.19
P/E Ratio (TTM)
63.57
Forward P/E
26.61
P/B Ratio
2.78
PEG Ratio
-1.16
Div. Yield
0.53%
ROE
4.72%
Beta
0.111
Debt to Equity
53.82
Financial Highlights
Profitability
Gross Margin
67.93%
Operating Margin
5.22%
Profit Margin
6.90%
Returns and Earnings
Return on Assets (TTM)
2.76%
Return on Equity (TTM)
4.72%
EBITDA
INR1.3B
Net Income (TTM)
INR275.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR74.99
Quarterly Revenue Growth (YoY)
7.70%
Quarterly Earnings Growth (YoY)
-55.60%
Dividend Information
Last 12-Month Dividend
₹2.00
Current Dividend Yield
0.53%
3-Year Average Dividend Yield
0.46%
3-Year Average Annual Dividend
₹0.67
3-Year Total Dividends
₹2.00
Ex-Dividend Date
September 20, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Tarsons Products TARSONS | 17.56B Small-cap | -3.72% | -14.71% | -13.52% | 9.94% | -19.25% | -28.78% | -57.67% | -59.98% |
| Poly Medicure POLYMED | 192.89B Mid-cap | 9.00% | 0.55% | -15.41% | -3.87% | -22.74% | -6.44% | 173.04% | 387.89% |
| Dr Agarwal's Health AGARWALEYE | 144.06B Mid-cap | 4.60% | 1.26% | 17.04% | 13.20% | 13.44% | 13.33% | 13.33% | 13.33% |
| Laxmi Dental LAXMIDENTL | 19.18B Small-cap | 0.27% | -27.10% | -11.14% | 0.23% | -36.45% | -31.95% | -31.95% | -31.95% |
| Prevest Denpro PREVEST | 6.42B Small-cap | 3.19% | -2.87% | 23.64% | 28.42% | -6.24% | -4.92% | 38.76% | 112.28% |
| Centennial Surgical CSURGSU | 583.55M Small-cap | -1.25% | 0.64% | 18.76% | 72.53% | 16.14% | 49.22% | 194.41% | 298.86% |
Ownership & Short Interest
Insider Ownership
74.99%
Institutional Ownership
8.25%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
102K
Average 90-Day Volume
57K
Tarsons Products Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Tarsons Products would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is TARSONS's 52-week high and low?
- In the last 52 weeks, Tarsons Products reached a high of ₹491.80 (on September 18, 2024) and a low of ₹280.00 (on February 18, 2025).
- What is the market cap and P/E ratio for TARSONS?
- Curious about Tarsons Products's size and valuation? Its market capitalization stands at 17.56B. When it comes to valuation, the P/E ratio (trailing twelve months) is 63.57, and the forward P/E (looking ahead) is 26.61.
- Does TARSONS pay dividends? If so, what's the yield?
- Yes, Tarsons Products is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.53%, and the company has paid an average of ₹0.67 per share annually over the past 3 years.
- Who are Tarsons Products's main competitors or similar companies to consider before investing?
When looking at Tarsons Products, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Poly Medicure
POLYMED192.89B Healthcare Medical Instruments & Supplies -6.44% 173.04% Dr Agarwal's Health
AGARWALEYE144.06B Healthcare Medical Instruments & Supplies 13.33% 13.33% Laxmi Dental
LAXMIDENTL19.18B Healthcare Medical Instruments & Supplies -31.95% -31.95% Prevest Denpro
PREVEST6.42B Healthcare Medical Instruments & Supplies -4.92% 38.76% Centennial Surgical
CSURGSU583.55M Healthcare Medical Instruments & Supplies 49.22% 194.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Tarsons Products Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Tarsons Products's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.72%, the Debt to Equity ratio from the most recent quarter is 53.82, and its Gross Profit Margin stands at 67.93%.
- What is the recent revenue and earnings growth for TARSONS?
- Looking at Tarsons Products's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.70%, and quarterly earnings saw a YoY growth of -55.60%.
- How much of TARSONS stock is held by insiders and institutions?
- Wondering who owns Tarsons Products stock? Company insiders (like executives and directors) hold about 74.99% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 8.25%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.